睡眠障碍中医诊疗一体化设备研发

注册号:

Registration number:

ITMCTR2024000641

最近更新日期:

Date of Last Refreshed on:

2024-11-03

注册时间:

Date of Registration:

2024-11-03

注册号状态:

Registration Status:

补注册

Retrospective registration

注册题目:

睡眠障碍中医诊疗一体化设备研发

Public title:

Research and Development of Integrated TCM Diagnosis and Treatment Equipment for Sleep Disorders

注册题目简写:

English Acronym:

研究课题的正式科学名称:

睡眠障碍中医诊疗一体化设备研发

Scientific title:

Research and Development of Integrated TCM Diagnosis and Treatment Equipment for Sleep Disorders

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

傅璐瑶

研究负责人:

马睿杰

Applicant:

Luyao Fu

Study leader:

Ruijie Ma

申请注册联系人电话:

Applicant telephone:

18457100195

研究负责人电话:

Study leader's telephone:

18057102851

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

1710591584@qq.com

研究负责人电子邮件:

Study leader's E-mail:

maria7878@sina.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

浙江省杭州市西湖区莫干山路219号

研究负责人通讯地址:

浙江省杭州市西湖区莫干山路219号

Applicant address:

No.219 Moganshan Road Xihu District Hangzhou Zhejiang

Study leader's address:

No.219 Moganshan Road Xihu District Hangzhou Zhejiang

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

浙江中医药大学附属第三医院

Applicant's institution:

The Third Affiliated Hospital of Zhejiang Chinese Medical University

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

ZSLL-KY-2023-063-01

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件

批准本研究的伦理委员会名称:

浙江中医药大学附属第三医院伦理委员会

Name of the ethic committee:

Ethics Committee of The Third Affiliated Hospital of Zhejiang Chinese Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2023/11/29 0:00:00

伦理委员会联系人:

闫坤

Contact Name of the ethic committee:

Kun Yan

伦理委员会联系地址:

浙江省杭州市西湖区莫干山路219号浙江中医药大学附属第三医院

Contact Address of the ethic committee:

No.219 Moganshan Road Xihu District Hangzhou Zhejiang

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 28 8542 4855

伦理委员会联系人邮箱:

Contact email of the ethic committee:

zslunli@163.com

研究实施负责(组长)单位:

浙江中医药大学附属第三医院

Primary sponsor:

The Third Affiliated Hospital of Zhejiang Chinese Medical University

研究实施负责(组长)单位地址:

浙江省杭州市西湖区莫干山路219号

Primary sponsor's address:

No.219 Moganshan Road Xihu District Hangzhou Zhejiang

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

浙江

市(区县):

杭州

Country:

China

Province:

Zhejiang

City:

Hangzhou

单位(医院):

浙江中医药大学附属第三医院

具体地址:

浙江省杭州市西湖区莫干山路219号

Institution
hospital:

The Third Affiliated Hospital of Zhejiang Chinese Medical University

Address:

No.219 Moganshan Road Xihu District Hangzhou Zhejiang

经费或物资来源:

课题经费(政府、本单位)

Source(s) of funding:

Research funds (government and the hospital)

研究疾病:

睡眠障碍

研究疾病代码:

Target disease:

Sleep disorder

Target disease code:

研究类型:

Study type:

观察性研究

Observational study

研究设计:

Study design:

队列研究

Cohort study

研究所处阶段:

Study phase:

其它

Others

研究目的:

(1)基于中医理论构建失眠和舌诊相关的核心技术的大数据算法,搭建神经系统领域“云数字诊疗生态”模块;(2)将舌象深度特征与多导睡眠监测进行融合,建立基于融合特征的失眠的辅助辨证模型;(3)挖掘失眠及其不同证候的舌象客观化特征表达及其定量关系;(4)建立基于舌象的失眠症诊断及辅助辨证模型,搭建一体化诊疗平台。

Objectives of Study:

(1) Build a big data algorithm of core technologies related to insomnia and tongue diagnosis based on the theory of traditional Chinese medicine and build a "cloud digital diagnosis and treatment ecology" module in the field of nervous system; (2) Tongue depth features were integrated with polysomnography to establish an assisted syndrome differentiation model for insomnia based on fusion features; (3) To explore the relationship of tongue image objectified features of insomnia and its different syndroms; (4) Establish a diagnosis and auxiliary syndrome differentiation model for insomnia based on tongue image and build an integrated diagnosis and treatment platform.

药物成份或治疗方案详述:

为观察性研究,不涉及治疗方案。

Description for medicine or protocol of treatment in detail:

This is an observational study not involving therapeutic regimen.

纳入标准:

①18岁≤年龄≤70岁; ②符合《睡眠障碍国际分类(第3版)》(ICSD-3)慢性失眠的诊断标准; ③匹兹堡睡眠质量指数(Pittsburgh sleep quality index,PSQI)评分>7分; ④入组前1个月内未服用苯二氮䓬类等失眠药物; ⑤沟通无障碍,可配合完成疗效评价; ⑥签署知情同意书,自愿参加本项研究者。

Inclusion criteria

①18 years old ≤ age≤70 years old; ② Meet the diagnostic criteria for chronic insomnia in the International Classification of Sleep Disorders 3rd Edition (ICSD-3); ③ Pittsburgh sleep quality index (PSQI) score >7; ④ did not take benzodiazepines and other insomnia drugs within 1 month before entering the group; ⑤ Communication barrier-free can cooperate with the completion of curative effect evaluation; ⑥ Sign the informed consent to participate in this study voluntarily.

排除标准:

①严重精神类疾病或器质性疾病; ②合并重要脏器功能障碍; ③因长期服用某些染色食物或药物而影响舌象者; ④舌体受伤或脑卒中等疾病致伸舌动作障碍、伸舌严重歪斜者; ⑤有严重认知障碍或精神异常等原因不能配合完成的患者; ⑥患者或其授权人不愿意签署书面知情同意书。

Exclusion criteria:

① Serious mental illness or organic disease; ② Combined with major organ dysfunction; ③The tongue image is affected by long-term use of certain dyed foods or drugs; ④Tongue injury or stroke and other diseases caused by tongue extension movement disorders extended tongue serious skew; ⑤Patients with severe cognitive impairment or mental abnormality who can not cooperate with the completion of the project; ⑥ Patients or their authorized persons are unwilling to sign written informed consent.

研究实施时间:

Study execute time:

From 2024-01-01

To      2026-12-31

征募观察对象时间:

Recruiting time:

From 2024-01-01

To      2024-12-31

干预措施:

Interventions:

组别:

健康人组

样本量:

50

Group:

healthy people group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

组别:

睡眠障碍组

样本量:

150

Group:

Sleep disorder group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

样本总量 Total sample size : 200

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

浙江

市(区县):

杭州

Country:

China

Province:

Zhejiang

City:

Hangzhou

单位(医院):

杭州市五云山医院(杭州市健康促进研究院)

单位级别:

尚未定级

Institution/hospital:

Hangzhou Wuyunshan Hospital (Hangzhou Institute for Health Promotion)

Level of the institution:

Not yet graded

国家:

中国

省(直辖市):

浙江

市(区县):

杭州

Country:

China

Province:

Zhejiang

City:

Hangzhou

单位(医院):

浙江中医药大学附属第三医院

单位级别:

三甲

Institution/hospital:

The Third Affiliated Hospital of Zhejiang Chinese Medical University

Level of the institution:

No.219 Moganshan Road Xihu District Hangzhou Zhejiang

国家:

中国

省(直辖市):

浙江

市(区县):

杭州

Country:

China

Province:

Zhejiang

City:

Hangzhou

单位(医院):

浙江省中医院

单位级别:

三甲

Institution/hospital:

Zhejiang Provincial Hospital of Chinese Medicine

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

浙江

市(区县):

杭州

Country:

China

Province:

Zhejiang

City:

Hangzhou

单位(医院):

杭州市中医院

单位级别:

三甲

Institution/hospital:

Hangzhou Hospital of Traditional Chinese Medicine

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

浙江

市(区县):

杭州

Country:

China

Province:

Zhejiang

City:

Hangzhou

单位(医院):

浙江省立同德医院

单位级别:

三甲

Institution/hospital:

Zhejiang Provincial tongde hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

舌象客观化特征

指标类型:

主要指标

Outcome:

Objective characteristics of tongue image

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

广泛性焦虑障碍量表

指标类型:

次要指标

Outcome:

Generalized Anxiety Disorder

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

匹兹堡睡眠指数量表

指标类型:

次要指标

Outcome:

Pittsburgh Sleep Quality Index

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

多导睡眠监测

指标类型:

次要指标

Outcome:

polysomnography

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

抑郁症自我评估量表

指标类型:

次要指标

Outcome:

Patient Health Questionnaire-9

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

失眠严重程度指数

指标类型:

次要指标

Outcome:

Insomnia Severity Index

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

none

Tissue:

人体标本去向

其它

说明

Fate of sample 

Others

Note:

征募研究对象情况:

正在进行

Recruiting

年龄范围:

最小 18
Min age years
最大 70
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

为观察性研究,不涉及随机分组

Randomization Procedure (please state who generates the random number sequence and by what method):

It is an observational study and does not involve random grouping.

盲法:

Blinding:

是否共享原始数据:

IPD sharing:

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

实验结束后联系课题负责人申请

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Contact the project leader to apply after the experiment is completed

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

研究者需根据研究方案要求把收集的数据填入病例报告表并用EXCEL软件进行数据的记录和管理。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Researchers need to fill in the collected data in the Case Report Form according to the research protocol requirements and use EXCEL software for data record and manage.

数据管理委员会:

Data Managemen Committee:

暂未确定

Not yet

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

国际传统医学临床试验注册平台 京ICP备07032215号-5 提示:推荐使用IE8.0以上版本 宽屏显示分辨率下使用系统